The YARS1 Gene DI-CMTC Genetic Test is a specialized diagnostic assessment conducted to identify mutations in the YARS1 gene, which are associated with Dominant Intermediate Charcot-Marie-Tooth disease (DI-CMTC). Charcot-Marie-Tooth disease is a group of inherited disorders that primarily affect the peripheral nerves, leading to muscle weakness and sensory problems, predominantly in the feet and legs. The YARS1 gene plays a crucial role in the proper functioning of neurons, and mutations in this gene can disrupt nerve function, contributing to the symptoms of DI-CMTC.
This genetic test involves analyzing the patient's DNA to detect any alterations in the YARS1 gene that may indicate the presence of DI-CMTC. It is a vital tool for clinicians in diagnosing the condition, allowing for a more targeted approach to treatment and management of symptoms. Additionally, understanding the genetic basis of the disease can provide important information for family planning and genetic counseling for affected families.
The test is offered at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the YARS1 Gene DI-CMTC Genetic Test is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the YARS1 gene. For patients and families affected by Charcot-Marie-Tooth disease, this test represents a critical step in understanding their condition and navigating the challenges it presents.
The MPZ Gene DI-CMTD Genetic Test is a specialized diagnostic tool designed to identify mutations in the MPZ gene, which are associated with a subtype of Charcot-Marie-Tooth disease known as Dominant Intermediate Charcot-Marie-Tooth Disease Type D (DI-CMTD). Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, and sometimes the hands and arms.
The MPZ gene plays a crucial role in the functioning and maintenance of the myelin sheath, a protective layer that surrounds nerve fibers. Mutations in this gene can disrupt the normal function of peripheral nerves, leading to the symptoms observed in DI-CMTD. Early and accurate diagnosis through the MPZ Gene DI-CMTD Genetic Test can be critical for the management and treatment of the condition, allowing for targeted therapies and interventions that can improve quality of life.
This genetic test is offered by DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The test is priced at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed to ensure accurate results. For individuals displaying symptoms of Charcot-Marie-Tooth disease or those with a family history of the condition, the MPZ Gene DI-CMTD Genetic Test can provide essential insights into their genetic makeup, guiding both patients and healthcare providers in making informed decisions about management and treatment strategies.
The GABRG2 Gene Dravet Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GABRG2 gene, which have been linked to Dravet Syndrome, a severe form of epilepsy that begins in infancy. This test is crucial for confirming the diagnosis, guiding treatment options, and providing information for family planning. Dravet Syndrome is characterized by frequent, prolonged seizures often triggered by high temperatures or fever, and it may lead to developmental delays and other neurological issues. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic changes in the GABRG2 gene that are associated with the syndrome.
The test is offered by DNA Labs UAE, a leading facility in genetic testing and diagnostics, ensuring high accuracy and reliability of the results. The cost of the GABRG2 Gene Dravet Syndrome Genetic Test is 4400 AED, reflecting the specialized nature of the test and the sophisticated technology used in the analysis. Opting for this test at DNA Labs UAE not only provides critical insights into the condition but also supports individuals and families in managing the implications of Dravet Syndrome with informed medical and lifestyle decisions.
The SCN2A Gene Dravet Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SCN2A gene, which have been linked to Dravet Syndrome. Dravet Syndrome is a severe form of epilepsy that emerges in the first year of life, characterized by frequent, prolonged seizures often triggered by high temperatures or fever. Beyond seizures, individuals with Dravet Syndrome may also experience developmental delays, speech and walking issues, sleep disturbances, and other health complications.
The SCN2A gene plays a crucial role in the function of brain cells by coding for a protein that is essential for the proper transmission of electrical signals in the nervous system. Mutations in this gene can disrupt these signals, leading to the symptoms observed in Dravet Syndrome. Identifying mutations in the SCN2A gene can confirm a diagnosis of Dravet Syndrome, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals.
The test offered by DNA Labs UAE involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in their state-of-the-art facilities. The cost of the test is 4400 AED, which reflects the sophisticated technology and expertise required to accurately identify mutations in the SCN2A gene.
By opting for the SCN2A Gene Dravet Syndrome Genetic Test, families and individuals gain access to crucial information that can guide clinical decisions, from medication choices to lifestyle adjustments, ultimately leading to better management of Dravet Syndrome.
The SCN9A Gene Dravet Syndrome Modifier Genetic Test is a specialized diagnostic assessment conducted at DNA Labs UAE, designed to identify mutations in the SCN9A gene, which are known to modify the severity and characteristics of Dravet Syndrome. Dravet Syndrome is a severe form of epilepsy that begins in infancy and is often associated with gene mutations, including those in the SCN1A gene. However, recent research has identified that variations in the SCN9A gene can also influence the disease's course and response to treatment.
This test, priced at 4400 AED, is crucial for individuals diagnosed with Dravet Syndrome or families with a history of the condition, as it provides valuable insights into the genetic underpinnings of the disease. Understanding the specific genetic variations can guide personalized treatment strategies, potentially improving the quality of life for those affected. The testing process at DNA Labs UAE involves a comprehensive analysis of the SCN9A gene, employing state-of-the-art genetic sequencing technologies to ensure accurate and reliable results.
By opting for the SCN9A Gene Dravet Syndrome Modifier Genetic Test, patients and healthcare providers can gain a deeper understanding of the genetic factors contributing to Dravet Syndrome, paving the way for more targeted and effective interventions.
The "IGBP1 Gene Corpus Callosum Agenesis with Mental Retardation, Ocular Coloboma, and Micrognathia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to detect mutations in the IGBP1 gene, which have been associated with a rare congenital condition characterized by the absence or underdevelopment of the corpus callosum (the part of the brain that connects the two hemispheres), intellectual disabilities, ocular coloboma (a defect in the eye's iris or retina), and micrognathia (a condition where the jaw is significantly smaller than normal).
The test plays a crucial role in the early diagnosis and management of the condition, providing essential information for healthcare providers and families. By understanding the genetic underpinnings of these symptoms, medical professionals can offer more personalized care plans, anticipate potential complications, and provide genetic counseling to affected families.
The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the IGBP1 gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, patients and healthcare providers can expect reliable and comprehensive results that can significantly impact the management of this rare condition.
The TUBB2A Gene Cortical Dysplasia Complex with Other Brain Malformations Type 5 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE. This test specifically targets the TUBB2A gene, mutations of which are associated with cortical dysplasia complex type 5, a rare genetic disorder that affects brain development. This condition can lead to a range of neurological problems, including developmental delays, seizures, and abnormalities in brain structure.
The test is designed to identify mutations in the TUBB2A gene, providing crucial information that can assist in the diagnosis, management, and treatment planning for affected individuals. By employing advanced genetic sequencing technologies, DNA Labs UAE ensures a high level of accuracy and reliability in the test results.
The cost of the TUBB2A Gene Cortical Dysplasia Complex with Other Brain Malformations Type 5 Genetic Test is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results. For families facing the challenges of cortical dysplasia and related brain malformations, this test represents a valuable tool in understanding the genetic underpinnings of the condition and navigating the path forward in terms of medical care and support.
The CR1 gene, also known as Complement Receptor 1, plays a critical role in the immune system by helping to regulate the complement system, which is part of the body's innate immune response. Mutations or deficiencies in the CR1 gene can lead to a range of immune system problems, including increased susceptibility to infections and autoimmune diseases.
A CR1 Deficiency Genetic Test is a specialized diagnostic tool used to detect mutations in the CR1 gene. This test is essential for individuals who may be experiencing symptoms related to immune system disorders or for those who have a family history of such conditions. Early detection through this genetic test can aid in the proper management and treatment of conditions associated with CR1 deficiency.
In the UAE, DNA Labs offers the CR1 Deficiency Genetic Test. The cost of the test is 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and advanced genetic testing services, providing accurate and reliable results. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, particularly concerning the CR1 gene, enabling them and their healthcare providers to make informed decisions about their health management and treatment options.
The TMCO1 Gene Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TMCO1 gene. These mutations are associated with a rare genetic disorder characterized by distinct facial features, abnormalities in skeletal development, and intellectual disability. The syndrome represents a complex condition that requires precise genetic analysis for accurate diagnosis and management.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the TMCO1 gene. This gene plays a crucial role in various developmental processes, and its mutation can lead to the syndrome's characteristic symptoms.
DNA Labs UAE offers this comprehensive genetic test for individuals showing symptoms of the syndrome or for those with a family history of genetic disorders. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in identifying the genetic mutations associated with this condition. The results from this test can provide essential information for families and healthcare providers, guiding potential treatment options and management strategies for affected individuals.
The SLC6A8 gene creatine deficiency syndrome, also known as X-linked creatine transporter defect, is a genetic disorder that affects creatine transport into cells. This condition is significant because creatine plays a crucial role in energy storage and supply within cells, especially in the brain and muscles. Individuals with this syndrome may experience developmental delay, intellectual disabilities, speech and language impairments, and behavioral problems due to the lack of adequate creatine in certain cells.
To diagnose this condition, a specific genetic test is available that targets the SLC6A8 gene. This test can confirm the presence of mutations in the SLC6A8 gene that are responsible for the disorder. It is particularly useful for individuals showing symptoms of the disorder or for families with a history of the condition who are considering having children.
In the UAE, this genetic test is offered by DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the SLC6A8 Gene Creatine Deficiency Syndrome X-Linked Genetic Test at DNA Labs UAE is 4400 AED. The test provides a crucial diagnostic tool for affected individuals and their families, enabling them to understand their condition better and to seek appropriate treatment and management strategies.
